Dr. Brian P. Grady, MD

Dr. Grady practices at Golden Gate Urology Inc in San Francisco, California.

Dr. Grady's NPI, 1417018813, was assigned on December 12, 2006. Dr. Grady graduated from Geisel School Of Medicine At Dartmouth in 1994. Dr. Grady's California license number on file is A605230.

Dr. Grady's primary practice is Golden Gate Urology Inc, at 2186 Geary Blvd, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 543-2830.

Dr. Grady's primary practice is Golden Gate Urology Inc in San Francisco, California. Dr. Grady is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Grady to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grady practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Grady's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Grady is board certified in urology by the American Board of Urology. Dr. Grady has a license on file in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Grady treats.

CMS data shows 1,191 Medicare services from Dr. Grady across 10 procedure codes in 2024, for 523 Medicare patients. Medicare paid $105,539 for them.

CMS counts 523 Medicare patients who saw Dr. Grady in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grady's median patient age at 72, with 15% women.

In 2024, Dr. Grady wrote 2,245 Medicare Part D claims for 590 patients. 91% of them were for generic drugs. CMS names the drug for 2,062 of them, across 29 drugs with 11 or more claims each, at $334,524 in total drug cost. In 2023, CMS named 2,003 claims across 30 drugs.

Dr. Grady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grady as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Grady, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Grady, published from 2005 to 2020. 2011 was the busiest year, with 2. The most frequent topics are Surface-Active Agents, Adsorption and Micelles. Dr. Grady has published most often in Langmuir. Dr. Grady's most frequent co-authors are Peter R. Carroll, MD, James J. Chang, MD and Joseph H. Franks, MD.

Dmand AI links Dr. Grady to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms and Urinary Bladder Neoplasms.

CMS Open Payments shows 394 general payments to Dr. Grady from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Profound Medical Corp. paid the most, $2,644.

Dr. Grady graduated from Geisel School Of Medicine At Dartmouth in 1994.

Dr. Grady is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.